| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.42 | 0.02 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |